Electroanalytical Determination of Trimetazidine in Pharmaceuticals and Synthetic Urine Using an Anodically Treated Boron-Doped Diamond (BDD) Electrode and Square Wave Voltammetry (SWV)

Cristiana L. Oliveira,Mauro C. dos Santos,Odonírio Abrahão Júnior,Renata P. Alves,Ricardo José de Mendonça,Robson Tadeu Soares de Oliveira,Cristiana L. OliveiraMauro C. dos SantosOdonírio Abrahão JúniorRenata P. AlvesRicardo José de MendonçaRobson Tadeu Soares de Oliveiraa Universidade Federal do Triângulo Mineiro – UFTM,Uberaba,Brazilb Universidade Federal do ABC,Santo André,Brazil
DOI: https://doi.org/10.1080/00032719.2024.2322042
2024-03-02
Analytical Letters
Abstract:Trimetazidine dihydrochloride is an anti-ischemic agent widely used in the treatment of coronary artery disease, more specifically in the treatment of angina. Here is reported a simple and sensitive electroanalytical methodology for quantifying trimetazidine in pharmaceutical and synthetic urine samples using square-wave voltammetry. The influence of anodic and cathodic treatments on boron-doped diamond (BDD) was evaluated. The best results for trimetazidine were obtained using a BDD treated anodically at +3.0 V versus Ag(s)/AgCl(s)/Cl - (aq., saturated KCl) for 300 s in 0.1 mol L −1 H 2 SO 4 . The determination of trimetazidine was carried out in Britton-Robinson buffer at pH 3. Trimetazidine oxidation reveals two well-defined irreversible oxidation peaks. A calibration relationship was obtained from 0.35 mg L -1 to 2.6 mg L −1 (R 2 = 0.997). Limits of detection and quantification for trimetazidine were 5.63 x 10 −9 and 1.88 x 10 −8 mol L −1 , respectively. Recovery values were between 97 and 101 % and 96.8 and 99.8 % in pharmaceutical and synthetic urine.
chemistry, analytical
What problem does this paper attempt to address?